rivastigmine has been researched along with Chronic Insomnia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Algharably, EEA; Bermpohl, F; Bittner, N; Brandl, EJ; Funk, CSM; Kreutz, R; Riemer, TG; Schmidt, A | 1 |
| Manni, R; Ossola, M; Pacchetti, C; Rustioni, V; Terzaghi, M; Zangaglia, R | 1 |
| Allison, M; Appel-Dingemanse, S; Ho, YY; Huang, HL; Kiese, B; Lefèvre, G; Pommier, F; Sedek, G | 1 |
1 review(s) available for rivastigmine and Chronic Insomnia
| Article | Year |
|---|---|
Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer's Disease and Parkinson's Dementia: Systematic Review and Meta-Analysis.
Topics: Acetylcholinesterase; Alzheimer Disease; Anorexia; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Parkinson Disease; Phenylcarbamates; Randomized Controlled Trials as Topic; Rivastigmine; Sleep Initiation and Maintenance Disorders | 2023 |
1 trial(s) available for rivastigmine and Chronic Insomnia
| Article | Year |
|---|---|
Pharmacokinetics and bioavailability of the novel rivastigmine transdermal patch versus rivastigmine oral solution in healthy elderly subjects.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Area Under Curve; Benzylamines; Biological Availability; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Cross-Over Studies; Dizziness; Female; Half-Life; Headache; Humans; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Phenethylamines; Phenols; Phenylcarbamates; Rivastigmine; Sleep Initiation and Maintenance Disorders; Solutions; Tandem Mass Spectrometry; Vomiting | 2008 |
1 other study(ies) available for rivastigmine and Chronic Insomnia
| Article | Year |
|---|---|
Agrypnia with nocturnal confusional behaviors in dementia with Lewy bodies: immediate efficacy of rivastigmine.
Topics: Aged; Confusion; Female; Humans; Lewy Body Disease; Neuroprotective Agents; Phenylcarbamates; Rivastigmine; Sleep Initiation and Maintenance Disorders | 2010 |